News Releases

Explore all the latest news from Johnson & Johnson Vision around the globe.*

Johnson & Johnson Vision on Track for Multinational Launch of New Contact Lens Innovation: ACUVUE® OASYS MAX 1-Day
Latest Johnson & Johnson Vision contact lens innovation to launch across the US, Canada and multiple European countries in autumn 2022 71% of eye care professionals say patients are reporting…
Johnson & Johnson Vision on Track for Multinational Launch of New Contact Lens Innovation: ACUVUE® OASYS MAX 1-Day
Johnson&Johnson VISION
Johnson & Johnson Vision Presents New Data on Myopia, Intraocular Lenses, Phacoemulsification, Dry Eye Drops, Vision Science and Refractive Technologies at the Association for Research in Vision and Ophthalmology 2022 Meeting
Myopia research validates need for approaches and programs that reduce myopia prevalence and severity to reduce visual impairment New research validates systems and methodologies used to evaluate…
Johnson & Johnson Vision Presents New Data on Myopia, Intraocular Lenses, Phacoemulsification, Dry Eye Drops, Vision Science and Refractive Technologies at the Association for Research in Vision and Ophthalmology 2022 Meeting
Acuvue
Johnson & Johnson Vision Named a Winner of Fast Company’s 2022 World Changing Ideas Awards for ACUVUE® Theravision™ with Ketotifen

World’s first and only drug-eluting daily disposable contact lens with an established antihistamine for an FDA-first in its new category

JACKSONVILLE, FL…

Johnson & Johnson Vision Named a Winner of Fast Company’s 2022 World Changing Ideas Awards for ACUVUE® Theravision™ with Ketotifen

Feature Stories

Johnson & Johnson Media Center

For more information about the latest Johnson & Johnson
news and publications visit the Media Center at www.jnj.com

Johnson & Johnson Media Center

Social Media LIVE

 

*Johnson & Johnson Vision medical device information contained in the News Releases are specific to the market highlighted and is not intended for dissemination outside the intended market.

PP2023OTH5448